Synvisc for Patellafemoral Syndrome

Synvisc, an osteoarthritis medication, is not one of the commonly recommended treatments used in the management of patellofemoral syndrome (also known as chondromalacia patella), damage to the cartilage of the knee. Synvisc is, however, used to manage osteoarthritis of the knee, according to the medication's manufacturer; only a physician can determine if synvisc is right to treat a condition.

Types

• Medline Plus reports that patellofemoral syndrome could be related to overuse of the knee, especially in younger people, or may be an indication of the presence of arthritis in older people.

Significance

• The appropriate treatment for patellofemoral syndrome depends on the underlying cause of the condition. If it is determined that the condition is an indication of arthritis in the knee, Synvisc may be appropriate, depending on a physician's recommendations.

Treatment

• The recommended treatments for patellofemoral syndrome include resting the knee and avoiding activities that stress the area, painkillers and physical therapy, according to the Mayo Clinic.

Complications

• Some people may require surgery to correct damage caused by patellofemoral syndrome. This may include arthroscopy to remove damaged cartilage or an operation to realign the kneecap, according to the Mayo Clinic.

Identification

• In order to be properly diagnosed with patellofemoral syndrome or with underlying osteoarthritis of the knee, concerned individuals should seek medical treatment, and follow doctor's recommendations for treatment.